HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

X Q Yu Selected Research

CAY10566

7/2016[Effect of hypoxia-inducible factor-2α/stearoyl-CoA desaturase-1 pathway on biological behaviors of hepatoma cells induced by hypoxia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


X Q Yu Research Topics

Disease

2Hepatocellular Carcinoma (Hepatoma)
01/2017 - 07/2016
2Peritonitis
03/2016 - 05/2008
1Allergic Rhinitis
02/2022
1Echinococcosis (Hydatid Cysts)
02/2022
1Diabetes Mellitus
11/2021
1Hyperkalemia
11/2021
1Sepsis (Septicemia)
08/2020
1Acute Kidney Injury (Acute Renal Failure)
08/2020
1Pneumonia (Pneumonitis)
05/2019
1Infections
09/2018
1Urinary Bladder Neoplasms (Bladder Cancer)
07/2017
1Neoplasms (Cancer)
01/2017
1Periodontal Diseases (Periodontal Disease)
01/2017
1Alveolar Bone Loss
01/2017
1Hypoxia (Hypoxemia)
07/2016
1Abdominal Aortic Aneurysm
05/2016
1Endoleak
05/2016
1Fistula
05/2013
1Rectal Fistula (Anal Fistula)
05/2013
1Diabetic Retinopathy (Retinopathy, Diabetic)
03/2013
1Diabetic Nephropathies (Diabetic Nephropathy)
03/2013
1Conversion Disorder (Astasia Abasia)
11/2009
1Lupus Nephritis
07/2008
1Fibrosis (Cirrhosis)
12/2007
1Peritoneal Fibrosis
12/2007
1Gram-Negative Bacterial Infections
12/2000
1Kidney Diseases (Kidney Disease)
10/2000
1Glomerulonephritis
02/2000

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
02/2022 - 07/2016
1OvalbuminIBA
02/2022
1Bicarbonates (Hydrogen Carbonate)IBA
11/2021
1Phosphorus (Red Phosphorus)IBA
11/2021
1CreatinineIBA
11/2021
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2021
1AngiotensinsIBA
11/2021
1Triglycerides (Triacylglycerol)IBA
11/2021
1Serum AlbuminIBA
11/2021
1CytokinesIBA
08/2020
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
08/2020
1salicylhydroxamic acid (SHAM)IBA
08/2020
1gremubamabIBA
05/2019
1AntibodiesIBA
09/2018
1Recombinant ProteinsIBA
09/2018
1EpitopesIBA
09/2018
1Interleukin-27 (Interleukin 27)IBA
07/2017
1Pharmaceutical PreparationsIBA
07/2017
1Sorafenib (BAY 43-9006)FDA Link
07/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2017
1Biological ProductsIBA
07/2016
1CAY10566IBA
07/2016
1Annexin A5IBA
07/2016
1stearoyl-coenzyme A (stearoyl-CoA)IBA
07/2016
1Messenger RNA (mRNA)IBA
07/2016
1Capsules (Microcapsules)IBA
03/2016
1Virulence Factors (Pathogenicity Factors)IBA
03/2016
1Membrane Proteins (Integral Membrane Proteins)IBA
03/2016
1Indicators and Reagents (Reagents)IBA
03/2013
1PowdersIBA
11/2009
1LithiumIBA
11/2009
1Prednisone (Sone)FDA LinkGeneric
07/2008
1Leflunomide (Arava)FDA LinkGeneric
07/2008
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2008
1Transforming Growth Factor beta (TGF-beta)IBA
12/2007
1Pattern Recognition ReceptorsIBA
12/2000
1OsteopontinIBA
10/2000
1Macrophage Migration-Inhibitory FactorsIBA
02/2000

Therapy/Procedure

3Peritoneal Dialysis
11/2021 - 12/2007
3Ligation
08/2020 - 05/2013
2Continuous Ambulatory Peritoneal Dialysis (CAPD)
03/2016 - 05/2008
1Renal Dialysis (Hemodialysis)
11/2021
1Laparotomy
08/2020
1Punctures
08/2020
1Critical Care (Surgical Intensive Care)
01/2017
1Length of Stay
05/2016
1Stents
05/2016
1Operative Time
05/2013
1Lasers (Laser)
11/2009
1Electrodes (Electrode)
11/2009
1Therapeutics
07/2008
1Microbubbles
12/2007